Best Practice Trends for Operational Excellence in Pharmaceuticals
Or, if you're already a Process Excellence member, sign in below to view this content. Sign In to Watch Become a member to Watch
The pharmaceutical industry is facing significant pressure to cut costs and deliver new therapies as they face expiring patents and competition from generic producers in low cost countries.
So what are the latest best practice strategies that leading pharmaceutical companies are adopting in order to simultaneously expand their markets while reducing costs?
Join this webinar to:
- Understand the latest strategies and technologies that pharmaceutical companies are using to more systematically expand in new markets with operational excellence and reduced costs
- Learn how to organize and prioritize product and process changes within your organization in a controlled and compliant way
- Explore how process excellence contributes to operational excellence and how things like data analytics are leading to better informed decision making
This webinar took place at 8:00 AM EDT (New York) / 13:00 BST (London) / 14:00 CEST (Paris) on 17 July.
If you missed the release time, don't worry - this webinar is now available on demand.
Research director, Alan S. Louie, Ph.D., is charged with spearheading IDC Health Insights' Clinical Development, Strategy and Technology research service with coverage spanning the entire life science R&D spectrum. In addition, he leads the company's research efforts focusing on translational research and personalized medicine
Dr. Louie brings more than 26 years of technical, product development, and business consulting experience from the diagnostics and biotechnology industries, including specific expertise in technology due diligence, in vitro diagnostic technology and product development, integrated device product development, automated biological sample handling, and consumer product development and commercialization projects.
Jean Colombel is currently the Vice President of the Life Sciences Industry at Dassault Systèmes (3DS). His organization is responsible for creating and developing 3DS strategy and associated solutions for pharmaceutical, medical devices and patient care industry segments. Since joining the company in 2009, Mr. Colombel has grown the Life Sciences business significantly and further enhanced the product portfolio by working with leading pharmaceutical, medical devices and healthcare organizations, while partnering and acquiring multiple business operations. Mr. Colombel has over 20 years of experience in the life sciences industry, supporting multiple functions and serving various executive level positions including senior vice president of worldwide sales and services. During the late 1980’s, he studied Medicinal Chemistry in Montpellier, France and led research activities at the Pharmaceutical Institute in Tubingen, Germany.